Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes

Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor in setting optimal chemotherapy regimes, with almost half of patients expected to develop congestive heart failure given high doses. However, the genetic basis of sensitivity to anthracyclines remains unclear. We created a panel of...

Descripción completa

Detalles Bibliográficos
Autores principales: Knowles, David A, Burrows, Courtney K, Blischak, John D, Patterson, Kristen M, Serie, Daniel J, Norton, Nadine, Ober, Carole, Pritchard, Jonathan K, Gilad, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2018
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010343/
https://www.ncbi.nlm.nih.gov/pubmed/29737278
http://dx.doi.org/10.7554/eLife.33480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010343/
https://www.ncbi.nlm.nih.gov/pubmed/29737278
http://dx.doi.org/10.7554/eLife.33480

Ejemplares similares